MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways
- PMID: 31837357
- DOI: 10.1016/j.jhep.2019.11.021
MUC13 promotes intrahepatic cholangiocarcinoma progression via EGFR/PI3K/AKT pathways
Abstract
Background & aims: Mucin 13 (MUC13) is reportedly overexpressed in human malignancies. However, the clinicopathological and biological significance of MUC13 in human intrahepatic cholangiocarcinoma (iCCA) remain unclear. The aim of this study was to define the role of MUC13 in the progression of iCCA.
Methods: Expression levels of MUC13 in human iCCA samples were evaluated by immunohistochemistry, western blot, and real-time PCR. In vitro and in vivo experiments were used to assess the effect of MUC13 on iCCA cell growth and metastasis. Crosstalk between MUC13 and EGFR/PI3K/AKT signaling was analyzed by molecular methods. The upstream regulatory effects of MUC13 were evaluated by Luciferase and DNA methylation assays.
Results: MUC13 was overexpressed in human iCCA specimens and iCCA cells. MUC13 overexpression positively correlated with clinicopathological characteristics of iCCA, such as vascular invasion and lymph node metastasis, and was independently associated with poor survival. Results from loss-of-function and gain-of-function experiments suggested that knockdown of MUC13 attenuated, while overexpression of MUC13 enhanced, the proliferation, motility, and invasiveness of iCCA cells in vitro and in vivo. Mechanistically, we found that the phosphatidylinositol 3-kinase-AKT signal pathway and its downstream effectors, such as tissue inhibitor of metalloproteinases 1 and matrix metallopeptidase 9, were required for MUC13-mediated tumor metastasis of iCCA. MUC13 interacted with epidermal growth factor receptor (EGFR) and subsequently activated the EGFR/PI3K/AKT signaling pathway by promoting EGFR dimerization and preventing EGFR internalization. We also found that MUC13 was directly regulated by miR-212-3p, whose downregulation was related to aberrant CpG hypermethylation in the promoter area.
Conclusions: These findings suggest that aberrant hypermethylation-induced downregulation of miR-212-3p results in overexpression of MUC13 in iCCA, leading to metastasis via activation of the EGFR/PI3K/AKT signaling pathway.
Lay summary: Mucin 13 overexpression has been implicated in the development of malignancies, although its role in intrahepatic cholangiocarcinoma has not been studied. Herein, we show that mucin 13 plays a critical role in intrahepatic cholangiocarcinoma. Mucin 13 could have therapeutic value both as a prognostic marker and as a treatment target.
Keywords: Kinase; Liver cancer; Mouse; Mucins; Prognostic factor; iCCA; miR-212-3p.
Copyright © 2019 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Epigenetic deregulation of MLF1 drives intrahepatic cholangiocarcinoma progression through EGFR/AKT and Wnt/β-catenin signaling.Hepatol Commun. 2023 Jul 24;7(8):e0204. doi: 10.1097/HC9.0000000000000204. eCollection 2023 Aug 1. Hepatol Commun. 2023. PMID: 37486965 Free PMC article.
-
CircZNF215 promotes tumor growth and metastasis through inactivation of the PTEN/AKT pathway in intrahepatic cholangiocarcinoma.J Exp Clin Cancer Res. 2023 May 18;42(1):125. doi: 10.1186/s13046-023-02699-w. J Exp Clin Cancer Res. 2023. PMID: 37198696 Free PMC article.
-
Tetraspanin 1 promotes epithelial-to-mesenchymal transition and metastasis of cholangiocarcinoma via PI3K/AKT signaling.J Exp Clin Cancer Res. 2018 Dec 4;37(1):300. doi: 10.1186/s13046-018-0969-y. J Exp Clin Cancer Res. 2018. PMID: 30514341 Free PMC article.
-
The role of Tripartite motif containing 59 (TRIM59) in the proliferation and prognosis of intrahepatic cholangiocarcinoma.Pathol Res Pract. 2022 Aug;236:153989. doi: 10.1016/j.prp.2022.153989. Epub 2022 Jun 17. Pathol Res Pract. 2022. PMID: 35753134 Review.
-
Role of ErbB family receptor tyrosine kinases in intrahepatic cholangiocarcinoma.World J Gastroenterol. 2008 Dec 14;14(46):7033-58. doi: 10.3748/wjg.14.7033. World J Gastroenterol. 2008. PMID: 19084911 Free PMC article. Review.
Cited by
-
Integrated Approaches Revealed the Therapeutic Mechanisms of Zuojin Pill Against Gastric Mucosa Injury in a Rat Model with Chronic Atrophic Gastritis.Drug Des Devel Ther. 2024 May 17;18:1651-1672. doi: 10.2147/DDDT.S454758. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38774485 Free PMC article.
-
Circ_0053943 complexed with IGF2BP3 drives uveal melanoma progression via regulating N6-methyladenosine modification of Epidermal growth factor receptor.Oncol Res. 2024 Apr 23;32(5):983-998. doi: 10.32604/or.2024.045972. eCollection 2024. Oncol Res. 2024. PMID: 38686044 Free PMC article.
-
Unveiling the gastric microbiota: implications for gastric carcinogenesis, immune responses, and clinical prospects.J Exp Clin Cancer Res. 2024 Apr 19;43(1):118. doi: 10.1186/s13046-024-03034-7. J Exp Clin Cancer Res. 2024. PMID: 38641815 Free PMC article. Review.
-
Deciphering cellular and molecular mechanism of MUC13 mucin involved in cancer cell plasticity and drug resistance.Cancer Metastasis Rev. 2024 Mar 18. doi: 10.1007/s10555-024-10177-8. Online ahead of print. Cancer Metastasis Rev. 2024. PMID: 38498072 Review.
-
Hypoxia-induced PLOD2 promotes clear cell renal cell carcinoma progression via modulating EGFR-dependent AKT pathway activation.Cell Death Dis. 2023 Nov 27;14(11):774. doi: 10.1038/s41419-023-06298-7. Cell Death Dis. 2023. PMID: 38008826 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous